Clinical Trial IDNCT03452267
Lead SponsorWayne State University
Principal Investigator
  • Kyle Jon Burghardt
Start Date2020-06-01
Completion Date2025-06-01
Study TypeInterventional
PhasePhase 2/Phase 3
StatusNot yet recruiting

Purpose

The insulin sensitizing effects of metformin and pioglitazone in the skeletal muscle remain unknown. Our group aims to analyze molecular changes within the skeletal muscle of pre-diabetic patients through the use of a clinical trial in humans.

Conditions

ConditionInterventionPhase
Insulin SensitivityDrug: Metformin, Drug: Pioglitazone, Drug: PlaceboPhase 2/Phase 3

Eligibility

AgeGenderAccepts Healthy Volunteers
18 Years to 60 YearsAllNo